RE: HEMO. For a truly brilliant synopsis of the True Position.20 Feb 2024 12:40
The Situation.
Prevail invested in HEMO at a 240% Premium.
HEMO was Pre clinical.
Prevail knew that HEMO would need funds for the trials.
Prevail is staffed by intelligent people with Industry experience.
They would not have invested in the initial amount, if they were not prepared to invest, with partners or on their own, to guarantee the Clinical trials can progress.